Michael Lazarus Selected Research

Michael Lazarus Research Topics

Disease

5	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2024 - 01/2014
4	Fever (Fevers) 07/2015 - 04/2006
3	Sleep Wake Disorders 01/2023 - 01/2019
3	Vascular Remodeling 10/2020 - 07/2013
3	Pain (Aches) 01/2020 - 02/2009
3	Inflammation (Inflammations) 01/2017 - 02/2009
2	Schizophrenia (Dementia Praecox) 01/2024 - 01/2023
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 01/2019
2	Mania (Manias) 01/2023 - 06/2020
2	Ulcerative Colitis 12/2020 - 01/2017
2	Hypoxia (Hypoxemia) 10/2020 - 03/2015
2	Pulmonary Hypertension 10/2020 - 03/2015
2	Infections 11/2019 - 07/2011
2	Flushing 01/2017 - 01/2017
2	Myocardial Infarction 01/2017 - 01/2017
2	Fistula 01/2013 - 08/2011
1	Chronic Pain 01/2024
1	Mental Disorders (Mental Disorder) 01/2024
1	Catalepsy 01/2024
1	Parkinsonian Disorders (Parkinsonism) 01/2024
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Narcolepsy 12/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Ataxia (Dyssynergia) 01/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Sleep Deprivation 01/2020
1	Hyperalgesia 01/2020
1	Epilepsy (Aura) 01/2020
1	Neoplasms (Cancer) 11/2019
1	Insulin Resistance 01/2019
1	Obesity 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Colitis 01/2017
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2017
1	Peritonitis 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017

Drug/Important Bio-Agent (IBA)

8	Prostaglandin D2IBA 12/2020 - 03/2014
7	ProstaglandinsIBA 01/2022 - 02/2009
4	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2020 - 01/2017
4	Dinoprostone (PGE2)FDA Link 02/2016 - 04/2006
3	Dopamine (Intropin)FDA LinkGeneric 01/2024 - 02/2016
3	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023 - 01/2019
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2024 - 06/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2024 - 11/2019
2	Modafinil (Provigil)FDA Link 12/2021 - 01/2020
2	MonocrotalineIBA 10/2020 - 03/2015
2	CytokinesIBA 01/2020 - 01/2017
2	Caffeine (No Doz)FDA LinkGeneric 01/2019 - 07/2011
2	CholesterolIBA 01/2019 - 01/2017
2	LipopolysaccharidesIBA 02/2009 - 04/2006
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2024
1	Antipsychotic Agents (Antipsychotics)IBA 01/2024
1	Haloperidol (Haldol)FDA LinkGeneric 01/2024
1	Levodopa (L Dopa)FDA LinkGeneric 01/2024
1	levodopa receptorIBA 01/2024
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	BenzodiazepinesIBA 01/2023
1	Diazepam (Valium)FDA LinkGeneric 01/2023
1	DORA-22IBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Orexin Receptor AntagonistsIBA 01/2023
1	sulprostoneIBA 01/2022
1	Semaxinib (SU5416)IBA 10/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2020
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 10/2020
1	Therapeutic UsesIBA 10/2020
1	Reserpine (Serpasil)FDA Link 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	InterferonsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Scopolamine (Hyoscine)FDA Link 01/2020
1	Superoxides (Superoxide)IBA 01/2020
1	HydroxylysineIBA 01/2020
1	Fatty Acid-Binding ProteinsIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019
1	AdiponectinIBA 01/2019
1	ParvalbuminsIBA 12/2017
1	Designer DrugsIBA 12/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	sym-trinitrobenzeneIBA 01/2017
1	prostaglandin D2 receptorIBA 01/2017
1	MK-0524IBA 01/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017
1	Sulfonic AcidsIBA 01/2017
1	ZymosanIBA 01/2017
1	Dextran SulfateIBA 01/2017
1	gamma-Aminobutyric Acid (GABA)IBA 02/2016
1	Divalent CationsIBA 10/2015

Therapy/Procedure

4	Therapeutics 01/2017 - 08/2011
2	Ligation 01/2020 - 01/2017
1	Induced Hypothermia 01/2023